Related Experiment Video
Updated: Sep 12, 2025

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Osteoclasts in osteoradionecrosis: Pathogenic mechanisms and emerging therapies
Feng Li1, Xinyuan Liu2, Anne-Laure Vandevelde1
1OMFS-IMPATH Research Group, Department of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium; Department of Oral and Maxillofacial Surgery, University Hospitals Leuven, Leuven, Belgium.
None:
Osteoradionecrosis (ORN) is a severe complication of radiation therapy characterized by impaired bone repair and regeneration, disrupting the delicate balance between osteoclast-mediated bone resorption and osteoblast-driven bone formation. Despite significant research, the intricate pathological mechanisms underlying ORN remain incompletely understood. Notably, while radiation therapy generally inhibits the function of most cells in bone tissue, its specific activation of osteoclasts is a key feature of ORN. Recent findings emphasize the pivotal role of excessive osteoclast activity in driving ORN progression. This review provides a comprehensive exploration of osteoclast adaptations within the unique bone microenvironment of ORN, shaped by hypoxia, immune dysfunction, and bacterial infections. It delves into the cellular stress responses-including oxidative stress, metabolic reprogramming, autophagy, and iron regulation-that further influence osteoclast function in ORN. By integrating these insights, we evaluate current therapeutic approaches and propose innovative osteoclast-targeted strategies to mitigate ORN. Through this synthesis of emerging evidence, the review sheds light on the complex interplay of factors contributing to ORN pathogenesis and highlights promising avenues for prevention and treatment, offering hope for improved clinical outcomes.
More Related Videos
Related Concept Videos
Osteoclasts in Bone Remodeling
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bone Remodeling
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

